on ABSCIENCES (EPA:AB)
AB Science postpones the publication of its 2024 annual financial report
AB Science SA, a company listed on Euronext Paris, announced that the publication of its 2024 annual financial report has been postponed to May 9, 2025. Initially scheduled for April 30, 2025, this decision was made to allow the statutory auditors to finalize their audit work. The publication will take place after the market closes.
AB Science specializes in the development of protein kinase inhibitors, a key technology in the treatment of serious pathologies. The company, founded in 2001, is headquartered in Paris. Masitinib, its flagship molecule, is the subject of promising developments in several medical fields.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABSCIENCES news